Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 17
2015 34
2016 23
2017 25
2018 18
2019 20
2020 9
2021 8
2022 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
RoB 2: a revised tool for assessing risk of bias in randomised trials.
Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT. Sterne JAC, et al. BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898. BMJ. 2019. PMID: 31462531 Free article. No abstract available.
ESPACOMP Medication Adherence Reporting Guideline (EMERGE).
De Geest S, Zullig LL, Dunbar-Jacob J, Helmy R, Hughes DA, Wilson IB, Vrijens B. De Geest S, et al. Ann Intern Med. 2018 Jul 3;169(1):30-35. doi: 10.7326/M18-0543. Epub 2018 Jun 26. Ann Intern Med. 2018. PMID: 29946690 Free PMC article.
Guidelines for the Content of Statistical Analysis Plans in Clinical Trials.
Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Doré C, Williamson PR, Altman DG, Montgomery A, Lim P, Berlin J, Senn S, Day S, Barbachano Y, Loder E. Gamble C, et al. JAMA. 2017 Dec 19;318(23):2337-2343. doi: 10.1001/jama.2017.18556. JAMA. 2017. PMID: 29260229 Free article.
Methodology of clinical trials for rare diseases.
Tudur Smith C, Williamson PR, Beresford MW. Tudur Smith C, et al. Best Pract Res Clin Rheumatol. 2014 Apr;28(2):247-62. doi: 10.1016/j.berh.2014.03.004. Best Pract Res Clin Rheumatol. 2014. PMID: 24974061 Review.
Research with children and young people: not on them.
Sammons HM, Wright K, Young B, Farsides B. Sammons HM, et al. Arch Dis Child. 2016 Dec;101(12):1086-1089. doi: 10.1136/archdischild-2015-309292. Epub 2016 May 4. Arch Dis Child. 2016. PMID: 27145791 No abstract available.
Biomarker-guided trials: Challenges in practice.
Antoniou M, Kolamunnage-Dona R, Wason J, Bathia R, Billingham C, Bliss JM, Brown LC, Gillman A, Paul J, Jorgensen AL. Antoniou M, et al. Contemp Clin Trials Commun. 2019 Nov 16;16:100493. doi: 10.1016/j.conctc.2019.100493. eCollection 2019 Dec. Contemp Clin Trials Commun. 2019. PMID: 31788574 Free PMC article.
Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies.
Avery KN, Williamson PR, Gamble C, O'Connell Francischetto E, Metcalfe C, Davidson P, Williams H, Blazeby JM; members of the Internal Pilot Trials Workshop supported by the Hubs for Trials Methodology Research. Avery KN, et al. BMJ Open. 2017 Feb 17;7(2):e013537. doi: 10.1136/bmjopen-2016-013537. BMJ Open. 2017. PMID: 28213598 Free PMC article. Review.
137 results